| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 152 |
| 1 | ASPIRIN 325 MG | 150 |
| 2 | ASPIRIN 81 MG | 150 |
| 3 | BISOPROLOL FUMARATE | 144 |
| 4 | GABAPENTIN | 127 |
| 5 | BACLOFEN | 112 |
| 6 | INTERFERON BETA-1A | 110 |
| 7 | LORAZEPAM | 108 |
| 8 | CALCIUM | 87 |
| 9 | DOXEPIN HYDROCHLORIDE | 86 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALUMINUM ACETATE | 1 | 0.0244 |
| 1 | 5-HYDROXYTRYPTOPHAN | 1 | 0.0189 |
| 2 | PYRIDOXINE HYDROCHLORIDE | 27 | 0.0099 |
| 3 | SODIUM CHLORIDE, CALCIUM CHLORIDE, AND POTASSIUM CHLORIDE | 1 | 0.0084 |
| 4 | PRAMIPEXOLE DIHYDROCHLORIDE | 36 | 0.0074 |
| 5 | MENADIONE | 1 | 0.0072 |
| 6 | DOXEPIN HYDROCHLORIDE | 86 | 0.0067 |
| 7 | IBERDOMIDE | 1 | 0.0067 |
| 8 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 3 | 0.0048 |
| 9 | AMPICILLIN AND SULBACTAM | 4 | 0.0045 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 229 |
| 1 | Corticosteroid [EPC] | 225 |
| 2 | Benzodiazepine [EPC] | 169 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 156 |
| 4 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 112 |
| 5 | Interferon beta [EPC] | 110 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 97 |
| 7 | Calcium [EPC] | 87 |
| 8 | Potassium Channel Blocker [EPC] | 84 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 76 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 49 | 0.0035 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 11 | 0.0023 |
| 2 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 3 | 0.0021 |
| 4 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 112 | 0.0013 |
| 5 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 6 | Potassium Channel Blocker [EPC] | 84 | 0.0012 |
| 7 | Non-Standardized Fungal Allergenic Extract [EPC] | 2 | 0.0009 |
| 8 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 3 | 0.0009 |
| 9 | Osmotic Diuretic [EPC] | 4 | 0.0008 |